Editorial
Published on 20 May 2024
Editorial: Sex differences and cardiovascular therapeutics
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1420293
- 1,216 views
Type at least 3 characters
90 articles
Original Research
Published on 13 May 2024
A real-world pharmacovigilance study of drug-induced QT interval prolongation: analysis of spontaneous reports submitted to FAERS
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1363382
- 3,385 views
- 2 citations
Review
Published on 09 May 2024
The role of lymphatic endothelial cell metabolism in lymphangiogenesis and disease
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1392816
- 3,144 views
- 2 citations
Original Research
Published on 25 Apr 2024
SGLT2 inhibition, plasma proteins, and heart failure: a proteome-wide Mendelian Randomization and colocalization study
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1371513
- 3,967 views
Review
Published on 23 Apr 2024
Clinical evidence and potential mechanisms of traditional Chinese medicine for refractory heart failure: a literature review and perspectives
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1369642
- 1,596 views
Review
Published on 18 Apr 2024
Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1372055
- 3,512 views
- 8 citations
Review
Published on 19 Mar 2024
Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1337154
- 9,343 views
- 4 citations
Mini Review
Published on 13 Mar 2024
Effect of statin add-on therapy on cardiovascular mortality
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1308695
- 3,262 views
- 1 citation
Review
Published on 01 Mar 2024
Silicon in prevention of atherosclerosis and other age-related diseases
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1370536
- 8,214 views
- 5 citations
Review
Published on 23 Feb 2024
Data sources and applied methods for paclitaxel safety signal discernment
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1331142
- 2,535 views
Original Research
Published on 14 Feb 2024
Anti-hypertensive effect of a novel angiotensin II receptor neprilysin inhibitor (ARNi) -S086 in DSS rat model
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1348897
- 3,282 views
- 3 citations
Systematic Review
Published on 13 Feb 2024
Efficacy and safety of tongxinluo capsule for angina pectoris of coronary heart disease: an overview of systematic reviews and meta-analysis
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1229299
- 2,358 views
- 2 citations
Review
Published on 15 Jan 2024
Intermediate and long-term residual cardiovascular risk in patients with established cardiovascular disease treated with statins
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1308173
- 2,734 views
- 1 citation
Editorial
Published on 15 Jan 2024
Editorial: New and emerging lipid-lowering therapies for reducing cardiovascular risk: beyond statins
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1364170
- 2,368 views
Study Protocol
Published on 08 Jan 2024
Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1290240
- 2,623 views
Study Protocol
Published on 03 Jan 2024
The effect of pituitrin on postoperative outcomes in patients with pulmonary hypertension undergoing cardiac surgery: a study protocol for a randomized controlled trial
in Cardiovascular Pharmacology and Drug Discovery
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2023.1269624
- 2,112 views